glp-1 for obesity houma New Pill Foundayo (Orforglipron) Gets FDA Approval Obesity Medicine | Healthcare Services

Regulates appetite*

The GLP-1 conversation is just beginning in Aotearoa and Im excited about the role we can play in supporting long-term health Business desk article: Our GLP-1 Support meals:

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month

AI nutrition coaching, meal planning, and fitness guidance

Learn about eligibility, deadlines, and how to file a claim.

Manage Weight